Ingigerdur Sverrisdottir

发表

Screening for Monoclonal Gammopathy of Undetermined Significance: A Population-Based Randomized Clinical Trial. First Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study

I. Olafsson, P. T. Onundarson, B. Agnarsson, 2021, Blood.

Prevalence of MGUS Is High in the Istopmm Study but the Prevalence of IgA MGUS Does Not Increase with Age in the Way Other Immunoglobulin Subtypes Do

I. Olafsson, P. T. Onundarson, B. Agnarsson, 2022, Blood.

Estimating Selection Bias in Previous Monoclonal Gammopathy of Undetermined Significance Research - the Importance of Screening: Results from the Population-Based Screening Study Iceland Screens, Treats or Prevents Multiple Myeloma (iStopMM)

I. Olafsson, P. T. Onundarson, B. Agnarsson, 2021, Blood.

Fractures and survival in multiple myeloma: results from a population-based study

T. Aspelund, Sigrún Thorsteinsdóttir, M. Björkholm, 2019, Haematologica.

Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance: a population‐based study

M. Björkholm, S. Lund, I. Turesson, 2019, British journal of haematology.

Improved survival in myeloma patients–a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden

A. Vangsted, J. Thorsen, I. Turesson, 2022, Haematologica.

Long-term immunity against tetanus and diphtheria after vaccination of allogeneic stem cell transplant recipients.

C. Wennerås, P. Ljungman, T. Bergström, 2023, Transplantation and cellular therapy.

Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study

I. Olafsson, P. T. Onundarson, B. Agnarsson, 2022, Blood Cancer Journal.

Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on Iceland Screens Treats or Prevents Multiple Myeloma (iStopMM) Study

I. Olafsson, P. T. Onundarson, B. Agnarsson, 2021, Blood.

Comorbidities in multiple myeloma and implications on survival: A population‐based study

T. Aspelund, M. Björkholm, I. Turesson, 2021, European journal of haematology.

Autoimmune Diseases Are Not Associated with Monoclonal Gammopathy of Undetermined Significance: Results of the Prospective Population-Based Istopmm Study

I. Olafsson, B. Agnarsson, T. Aspelund, 2022, Blood.

Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study

I. Olafsson, B. Agnarsson, Sigrún Thorsteinsdóttir, 2023, Haematologica.

Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance

P. T. Onundarson, B. Agnarsson, T. Aspelund, 2024, Annals of Internal Medicine.